Archives of Toxicology

, Volume 88, Issue 9, pp 1749–1763

MicroRNA-34a is dispensable for p53 function as teratogenesis inducer

Reproductive Toxicology

DOI: 10.1007/s00204-014-1223-9

Cite this article as:
Mor, E., He, L., Torchinsky, A. et al. Arch Toxicol (2014) 88: 1749. doi:10.1007/s00204-014-1223-9


The tumor suppressor protein p53 is a powerful regulator of the embryo’s susceptibility to diverse teratogenic stimuli, functioning both as a teratogenesis inducer and suppressor. However, the targets that p53 engages to fulfill its functions remain largely undefined. We asked whether the microRNA (miRNA) miR-34 family, identified as one of the main targets of p53, mediates its function as a teratogenesis inducer. For this, pregnant ICR-, p53- and miR-34a-deficient mice, as well as rats, were exposed to 5-aza-2′-deoxycytidine (5-aza), a teratogen inducing limb reduction anomalies (LRA) of the hindlimbs in mice and either the hindlimbs or forelimbs in rats. Using hind- and forelimb buds of 5-aza-exposed embryos, we identified that the miR-34 family members are the most upregulated miRNAs in mouse and rat limb buds, with their increase level being significantly higher in limb buds destined for LRA. We showed that p53 mediates the 5-aza-induced miR-34 transcription followed by met proto-oncogene and growth-arrest-specific 1 target suppression in embryonic limb buds. We demonstrated that p53 regulates the teratogenic response to 5-aza acting as a teratogenesis inducer albeit miR-34a deletion does not affect the susceptibility of mice to 5-aza. Overall, our study thoroughly characterizes the expression and regulation of miR-34 family in teratogen-resistant and teratogen-sensitive embryonic structures and discusses the involvement of epigenetic miRNA-mediated pathway(s) in induced teratogenesis.


miRNA microRNA miR-34 Limbs Development p53 Teratogens 

Supplementary material

204_2014_1223_MOESM1_ESM.doc (30 kb)
Supplementary material 1 (DOC 30 kb)
204_2014_1223_MOESM2_ESM.jpg (46 kb)
Supplementary material 2 (JPEG 45 kb)
204_2014_1223_MOESM3_ESM.xls (93 kb)
Supplementary material 3 (XLS 93 kb)
204_2014_1223_MOESM4_ESM.doc (30 kb)
Supplementary material 4 (DOC 30 kb)
204_2014_1223_MOESM5_ESM.doc (30 kb)
Supplementary material 5 (DOC 30 kb)
204_2014_1223_MOESM6_ESM.doc (28 kb)
Supplementary material 6 (DOC 28 kb)

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Sackler Faculty of MedicineTel-Aviv UniversityTel AvivIsrael
  2. 2.Division of Cellular and Developmental Biology, Molecular and Cell Biology DepartmentUniversity of California at BerkeleyBerkeleyUSA

Personalised recommendations